Pradžia › Sklerodermija › Ilinoisas › Chicago

Sklerodermija klinikiniai tyrimai Chicago, IL

10 tyrimai dėl Sklerodermija ieško dalyvių vietose Chicago ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

Renkami dalyviai3 fazė

Northwestern University, Chicago
The University of Chicago Medical Center, Chicago

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07497087

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

Renkami dalyviai2 fazė

University of Illinois Health Outpatient Care Center, Chicago

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT06655155

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Renkami dalyviai1 fazė

The University of Chicago Medical Center, Chicago

Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-09-10 · NCT07085104

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Renkami dalyviai2/3 fazė

GSK Investigational Site, Chicago

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT05878717

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Renkami dalyviai1 fazė

Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago

Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-08-28 · NCT06925542

Platform Clinical Study for Conquering Scleroderma

Renkami dalyviai2 fazė

The University of Chicago Medical Center (UCMC), Chicago

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Renkami dalyviai2/3 fazė

Northwestern Memorial Hospital, Chicago
The University of Chicago Medical Center, Chicago

Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-17 · NCT06328777

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Renkami dalyviai1/2 fazė

Nkarta Investigational Site, Chicago

Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-07 · NCT06733935

A Study of AZD0120 in Autoimmune Diseases

Renkami dalyviai1 fazė

Research Site, Chicago

Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-07-28 · NCT07295847

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Renkami dalyviai2 fazė

aTyr Investigative Site, Chicago
aTyr Investigative Site, Chicago
aTyr Investigative Site, Chicago

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-05-07 · NCT05892614

Sklerodermija tyrimai kituose miestuose

Kiti tyrimai Chicago

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.